Clinical Hemorheology and Microcirculation - Volume 8, issue 5
Purchase individual online access for 1 year to this journal.
Price: EUR 185.00
Impact Factor 2020: 1.741
Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research.
The endeavour of the Editors-in-Chief and publishers of
Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of
Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process.
Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.
The following professionals and institutions will benefit most from subscribing to
Clinical Hemorheology and Microcirculation: medical practitioners in all fields including hematology, cardiology, geriatrics, angiology, surgery, obstetrics and gynecology, ophthalmology, otology, and neurology. Pharmacologists, clinical laboratories, blood transfusion centres, manufacturing firms producing diagnostic instruments, and the pharmaceutical industry will also benefit.
Important new topics will increasingly claim more pages of
Clinical Hemorheology and Microcirculation: the role of hemorheological and microcirculatory disturbances for epidemiology and prognosis, in particular regarding cardiovascular disorders, as well as its significance in the field of geriatrics. Authors and readers are invited to contact the editors for specific information or to make suggestions.
Abstract: Four normal women and two heterozygous β -thalassemic women were examined throughout one or more menstrual cycles for variations in several rheological parameters and red cell metabolism during the menstrual, follicular and luteal phases. Cyclic variations were found in the physical and chemical properties of the red cells (including mean corpuscular hemoglobin concentration, intracellular contents of 2,3-diphosphoglycerate and adenosine triphosphate, and erythrocyte deformability). These physiological changes during the menstrual cycle are exaggerated in heterozygous B-thalassemic women.
Keywords: Blood Rheology, Heterozygous Thalassemia, Menstrual Cycle, Red Cell Aggregation, Red Cell Deformability, Red Cell Metabolism
Abstract: In a series 43 patients suffering from cerebral or peripheral diseases were investigated over a period of 3 days after a single hypervolemic hemodilution with 500ml low molecular weight dextran (Rheomacrodex® ) applied within 3 hours. Changes in hematocrit, visco-elasticity of whole blood and plasma viscosity were studied. 18 to 36 hours after onset of infusion a significant increase in plasma viscosity (p ⩽ 0.001 ) and elasticity (p ⩽ 0.01 ) could be observed. Furthermore, there was a tendency towards higher hematocrit and whole blood viscosity levels. However, after 60 hours a second lower…numerical peak for hematocrit and viscosity of whole blood could be seen, which was yet above starting values.
Abstract: The present study evaluates the whole blood filterability index (WB-FI) and the washed red blood cell filterability index (WRBC-FI) in 21 chronic cerebrovascular insufficiency (CCVI) patients and in 36 control subjects. Althoug no significant differences were found in the mean values of the two groups, approximately 30% of the patients had a decreased WB-FI. Of the 7 CCVI patients who showed reduced WB-FI, this decrease could be attributed to erythrocyte deficiency in only two of the cases. Of the 21 CCVI patients, pentoxifylline (POX) was administered to 9, dipyridamole (DIP) to 6 and POX+DIP to another 6. The changes…in WB-FI were evaluated 7, 15 and 45 days after treatment was begun. POX and DIP administered separately favoured WB-FI at 15 and 7 days respectively, but when administered together, WB-FI only increased slightly on the 45th day.
Abstract: Piracetam (2-oxo-1-pyrrolidine acetamide) has been reported to have a beneficial rheological effect on sickle cells although its mode of action has remained unclear. When the Ca2+ -ionophore A23187 was used to induce loss of K+ and water from sickle cells from 20 patients, the consequential loss of erythrocyte filterability through pores of 5 µm diameter was partially corrected by piracetam at concentrations of 0.1-100 mmol/l (p < 0.002 - < 0.02). No beneficial effect of piracetam was found when sickle cells were dehydrated using the K+ ionophore valinomycin. Piracetam therefore prevents cation (K+ ) loss, via the Gardos…channel, from Ca2+ -loaded erythrocytes and may thereby inhibit the dehydration of sickle cells.